(Q33599648)

English

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation (English)

1 reference

Europe PubMed Central

28 July 2017

viral persistence

0 references

multiple sclerosis

0 references

Epstein–Barr virus

0 references

Barbara Rosicarelli

object named as

Barbara Rosicarelli

4

0 references

Caterina Veroni

object named as

Caterina Veroni

5

0 references

object named as

Martina Severa

2

0 references

Francesca Aloisi

object named as

Francesca Aloisi

10

0 references

Barbara Serafini

object named as

Barbara Serafini

1

0 references

author name string

Sandra Columba-Cabezas

3

1 reference

Europe PubMed Central

28 July 2017

Giuseppe Chiappetta

6

1 reference

Europe PubMed Central

28 July 2017

Roberta Magliozzi

7

1 reference

Europe PubMed Central

28 July 2017

Richard Reynolds

8

1 reference

Europe PubMed Central

28 July 2017

Eliana Marina Coccia

9

1 reference

Europe PubMed Central

28 July 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

28 July 2017

Journal of Neuropathology & Experimental Neurology

1 reference

Europe PubMed Central

28 July 2017

69

1 reference

Europe PubMed Central

28 July 2017

7

1 reference

Europe PubMed Central

28 July 2017

677-693

1 reference

Europe PubMed Central

28 July 2017

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Environmental factors and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

EBV in MS: guilty by association?

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Multiple sclerosis is linked to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

An attempt to investigate the presence of Epstein Barr virus in multiple sclerosis and normal control brain tissue

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

B cells and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Antibodies as biological markers for pathophysiological processes in MS.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

B cells under influence: transformation of B cells by Epstein–Barr virus

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus latent membrane protein 2A and autoimmunity

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Antigen receptors on B lymphocytes

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

The intersection of Epstein-Barr virus with the germinal center

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

"Out-of-pitch" but still "in-time". An auditory psychophysical study in congenital amusic adults

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

BCMA is essential for the survival of long-lived bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E3181E332EC

21 January 2018

Identifiers

10.1097/NEN.0B013E3181E332EC

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33599648&oldid=1786008660"